Five-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy

American Journal of Ophthalmology

Volumn 155, Issue 3, 2013, Pages 438-447.e1

  Kang, Hae Min ^a   Kim, Yong Min ^b   Koh, Hyoung Jun ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Siloan Eye Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB; VERTEPORFIN;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DETERIORATION; ENDOPHTHALMITIS; EYE DISEASE; EYE POLYP; FEMALE; FOLLOW UP; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; INTRAOCULAR HYPERTENSION; LONG TERM CARE; MALE; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; POLYP; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA DETACHMENT; RETROSPECTIVE STUDY; SUBRETINAL NEOVASCULARIZATION; SYSTEMIC DISEASE; VISUAL ACUITY;

EID: 84873729481     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2012.09.020     Document Type: Article

References (30)

1. L.A. Yannuzzi, J. Sorenson, R.F. Spaide, and B. Lipson Idiopathic polypoidal choroidal vasculopathy (IPCV) Retina 10 1 1990 1 8
2. R.F. Spaide, L.A. Yannuzzi, J.S. Slakter, J. Sorenson, and D.A. Orlach Indocyanine green videoangiography of idiopathic choroidal vasculopathy Retina 15 2 1995 100 110
3. L.A. Yannuzzi, A. Ciardella, R.F. Spaide, M. Rabb, K.B. Freund, and D.A. Orlack The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy Arch Ophthalmol 115 4 1997 478 485
4. L.A. Yannuzzi, D.W. Wong, and B.S. Sforzolini Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration Arch Ophthalmol 117 11 1999 1503 1510
5. K.G. Au Eong Age-related macular degeneration: an emerging challenge for eye care and public health professionals in the Asia Pacific region Ann Acad Med Singapore 35 3 2006 133 135
6. F. Gomi, and Y. Tano Polypoidal choroidal vasculopathy and treatments Curr Opin Ophthalmol 19 3 2008 208 212
7. A. Koh, T.H. Lim, and K.G. Au Eong Optimizing the management of choroidal neovascularization in Asian patients: consensus on treatment recommendations for anti-VEGF therapy Singapore Med J 52 4 2011 232 240
8. M. Uyama, M. Wada, and Y. Nagai Polypoidal choroidal vasculopathy: natural history Am J Ophthalmol 133 5 2002 639 648
9. F. Gomi, M. Ohji, and K. Sayanagi One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculoopathy in Japanese patients Ophthalmology 115 1 2008 141 146
10. W.M. Chan, D.S. Lam, and T.Y. Lai Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy Ophthalmology 111 8 2004 1576 1584
11. A. Otani, M. Sasahara, and Y. Yodoi Indocyanine green angiography guided photodynamic therapy for polypoidal choroidal vasculopathy Am J Ophthalmol 144 1 2007 7 14
12. F. Gomi, M. Sawa, and H. Sakaguchi Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy Br J Ophthalmol 92 1 2008 70 73
13. N. Hussain, A. Hussain, and S. Natrajan Role of photodynamic therapy in polypoidal choroidal vasculopathy Indian J Ophthalmol 53 2 2005 101 104
14. S.C. Lee, Y.S. Seong, S.S. Kim, H.J. Koh, and O.J. Kwon Photodynamic therapy with verteporfin for polypoidal vasculopathy of the macula Ophthalmologica 218 3 2004 193 201
15. R.M. Silva, J. Figueira, M.L. Cachulo, L. Duarte, J.R. Faria de Abreu, and J.G. Cunha-Vaz Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin Graefes Arch Clin Exp Ophthalmol 243 10 2005 973 979
16. E. Akaza, M. Yuzawa, Y. Matsumoto, S. Kashiwakura, K. Fujita, and R. Mori Role of photodynamic therapy in polypoidal choroidal vasculoopathy Jpn J Ophthalmol 51 4 2007 270 277
17. A. Koh, W.K. Lee, and L.J. Chen EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy Retina 32 8 2012 1453 1464
18. S. Leal, R.M. Silva, and J. Figueira Photodynamic therapy with verteporfin in polypoidal choroidal vasculopathy: results after 3 years of follow-up Retina 30 8 2010 1197 1205
19. E. Akaza, R. Mori, and M. Yuzawa Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy Retina 28 5 2008 717 722
20. E. Akaza, M. Yuzawa, and R. Mori Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy Jpn J Ophthalmol 55 1 2011 39 44
21. K. Sayanagi, F. Gomi, M. Sawa, M. Ohji, and Y. Tano Long-term follow-up of polypoidal choroidal vasculopathy after photodynamic therapy with verteporfin Graefes Arch Clin Exp Ophthalmol 245 10 2007 1569 1571
22. S. Honda, Y. Kurimoto, and Y. Kagotani Photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a 30-month multicenter study in Hyogo, Japan Jpn J Ophthalmol 53 6 2009 593 597
23. J.T. Holladay Proper method for calculating average visual acuity J Refract Surg 13 4 1997 388 391
24. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report Arch Ophthalmol 117 10 1999 1329 1345
25. Verteporfin in Photodynamic Therapy Study Group Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-Verteporfin in Photodynamic Therapy Report 2 Am J Ophthalmol 131 5 2001 541 560
26. T.H. Lim, A. Laude, and C.S.H. Tan Polypoidal choroidal vasculopathy: an angiographic discussion Eye 24 3 2010 483 490
27. M. Kim, K. Kim, D.G. Kim, S.Y. Yu, and H.W. Kwak Two-year results of photodynamic therapy combined with intravitreal anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy Ophthalmologica 226 4 2011 205 213
28. T. Sato, S. Kishi, H. Matsumoto, and R. Mukai Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy Am J Ophthalmol 149 6 2010 947 954
29. F. Gomi, M. Sawa, T. Wakabayashi, Y. Sasamoto, M. Suzuki, and M. Tsujikawa Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy Am J Ophthalmol 150 1 2010 48 54
30. P. Ruamviboonsuk, M. Tadarati, S. Vanichvaranont, P. Hanutsaha, and N. Pokawattana Photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy: results of a 1-year preliminary study Br J Ophthalmol 94 8 2010 1045 1051